Severe acute rhabdomyolysis associated with Streptococcus equi infection in four horses

Journal of the American Veterinary Medical Association

Volumn 227, Issue 11, 2005, Pages

  Sponseller, Beatrice T ^a   Valberg, Stephanie J ^b   Tennent Brown, Brett S ^c   Foreman, Jonathan H ^c   Kumar, Pawan ^d,e   Timoney, John F ^d  

^a IOWA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c University of Illinois at Urbana Champaign   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e CCS HARYANA AGRICULTURAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACEPROMAZINE; ALPHA TOCOPHEROL; DETOMIDINE; DIMETHYL SULFOXIDE; FLUNIXIN MEGLUMINE; GENTAMICIN; METHOCARBAMOL; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G SODIUM; RINGER LACTATE SOLUTION; SEDATIVE AGENT; SELENIUM; STEROID;

ABSCESS; BACTERIUM IDENTIFICATION; DISEASE ASSOCIATION; EDEMA; FEMALE; GLUTEUS MAXIMUS MUSCLE; HISTOPATHOLOGY; HORSE; IMMUNOFLUORESCENCE; MUSCLE NECROSIS; NONHUMAN; REVIEW; RHABDOMYOLYSIS; SKELETAL MUSCLE; STREPTOCOCCUS EQUI; STREPTOCOCCUS INFECTION; SUBMANDIBULAR GLAND; UPPER RESPIRATORY TRACT INFECTION;

ACUTE DISEASE; ANIMALS; FATAL OUTCOME; FEMALE; HORSE DISEASES; HORSES; IMMUNOHISTOCHEMISTRY; LAMENESS, ANIMAL; MALE; MUSCLE, SKELETAL; RHABDOMYOLYSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS EQUI;

BACTERIA (MICROORGANISMS); EQUIDAE; EQUUS CABALLUS; STREPTOCOCCUS; STREPTOCOCCUS EQUI;

EID: 28444443335     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2005.227.1800     Document Type: Review

References (50)

1. Timoney JP, Artiushin SC. Detection of Streptococcus equi in equine nasal swabs and washes by DNA amplification. Vet Rec 1997;141:446-447.
2. Timoney JF, Artiushin SC, Boschwitz JF. Comparison of the sequences and functions of Streptococcus equi M-like proteins SeM and SzPSe. Infect Immun 1997;65:3600-3605.
3. Artiushin SC, Timoney JF, Sheoran AS, et al. Characterization and immunogenicity of pyrogenic mitogens SePE-H and SePE-I of Streptococcus equi. Microb Pathog 2002;32:71-85.
4. Al-Ghamdi GM, Kapur V, Ames TR, et al. Use of repetitive sequence-based polymerase chain reaction for molecular epidemiologic analysis of Streptococcus equi subspecies equi. Am J Vet Res 2000;61:699-705.
5. Freestone JF, Carlson GR. Muscle disorders in the horse: a retrospective study. Equine Vet J 1991;23:86-90.
6. Pellegrini-Masini A, Dolente BA, Habecker PL, et al. Myonecrosis and cutaneous infarction associated with Salmonella serovar Infantum infection in a horse. J Am Vet Med Assoc 2004; 225:722-725, 699.
7. Traub-Dargatz JL, Schlipf JW Jr, Granstrom DE, et al. Multifocal myositis associated with Sarcocystis sp in a horse. J Am Vet. Med Assoc 1994;205:1574-1576.
8. Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis. Medicine (Baltimore) 1982;61:141-152.
9. Singh U, Scheld WM. Infectious etiologies of rhabdomyolysis: three case reports and review. Clin Infect Dis 1996;22:642-649.
10. Spataro V, Marone C. Rhabdomyolysis associated with bacteremia due to Streptococcus pneumoniae: case report and review. Clin Infect Dis 1993;17:1063-1064.
11. Shih KY, Chu TS, Hung CC, et al. Rhabdomyolysis associated with Streptococcus pneumoniae bacteremia in a splenectomized patient. J Formos Med Assoc 2002;101:429-431.
12. Garcia MC, Ebeo CT, Byrd RP, et al. Rhabdomyolysis associated with pneumococcal pneumonia: an early clinical indicator of increased morbidity? Tenn Med 2002;95:67-69.
13. Asao K, Utsunomiya Y, Hirano K, et al. Rhabdomyolysis associated with bacteremia due to Streptococcus viridans. Intern Med 1995;34:785-789.
14. Martino R, Nomdedeu J, Sureda A, et al. Acute rhabdomyolysis complicating viridans streptococcal shock syndrome. Acta Haematol 1994;92:140-141.
15. Svane S. Peracute spontaneous streptococcal myositis. A report on 2 fatal cases with review of literature. Acta Chir Scand 1971;137:155-163.
16. Adams EM, Gudmundsson S, Yocum DE, et al. Streptococcal myositis. Arch Intern Med 1985;145:1020-1023.
17. Gardam MA, Low DE, Saginur R, et al. Group B streptococcal necrotizing fasciitis and streptococcal toxic shock-like syndrome in adults. Arch Intern Med 1998;158:1704-1708.
18. Ojttkwu IC, Newton DW, Luque AE, et al. Invasive group C Streptococcus infection associated with rhabdomyolysis and disseminated intravascular coagulation in a previously healthy adult. Scand J Infect Dis 2001;33:227-229.
19. Korman TM, Boers A, Gooding TM, et al. Fatal case of toxic shock-like syndrome due to group C Streptococcus associated with superantigen exotoxin. J Clin Microbiol 2004;42:2866-2869.
20. Wagner JG, Schlievert PM, Assimacopoulos AP, et al. Acute group G streptococcal myositis associated with streptococcal toxic shock syndrome: case report and review. Clin Infect Dis 1996;23: 1159-1161.
21. Humar D, Datta V, Bast DJ, et al. Streptolysin S and necrotising infections produced by group G Streptococcus. Lancet 2002; 359:124-129.
22. Piepmeier E Jr, Hammett-Stabler C, Price M, et al. Myositis and fasciitis associated with group A beta hemolytic streptococcal infections: development of a rabbit model. J Lab Clin Med 1995;126:137-143.
23. Haywood CT, McGeer A, Low DE. Clinical experience with 20 cases of group A streptococcus necrotizing fasciitis and myonecrosis: 1995 to 1997. Plast Reconstr Surg 1999;103:1567-1573.
24. Betrosian A, Thireos E, Kofinas G, et al. Bacterial sepsis-induced rhabdomyolysis. Intensive Care Med 1999;25:469-474.
25. Blanco JR, Zabalza M, Salcedo J, et al. Rhabdomyolysis of infectious and noninfectious causes. South Med J 2002;95:542-544.
26. Kaese HJ, Valberg SJ, Hayden DW. Infarctive purpura hemorrhagica in five horses. J Am Vet Med Assoc 2005;226:1893-1898.
27. Valberg SJ, Bullock P, Hogetvedt W, et al. Myopathies associated with Streptococcus equi infections in horses, in Proceedings. 42nd Annu Conv Am Assoc Equine Pract 1996;292-293.
28. The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. JAMA 1993;269:390-391.
29. Schlievert PM. Role of superantigens in human disease. J Infect Dis 1993;167:997-1002.
30. Kotb M. Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 1995;8:411-426.
31. Proft T, Webb PD, Handley V, et al. Two novel superantigens found in both group A and group C streptococcus. Infect Immun 2003;71:1361-1369.
32. Herwald H, Cramer H, Morgelin M, et al. M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 2004;116:367-379.
33. Brown EJ. The molecular basis of streptococcal toxic shock syndrome. N Engl J Med 2004;350:2093-2094.
34. Dolente BA, Seco OM, Lewis ML. Streptococcal toxic shock in a horse. J Am Vet Med Assoc 2000;217:64-67, 30.
35. Holbrook TC, Munday JS, Brown CA, et al. Toxic shock syndrome in a horse with Staphylococcus aureus pneumonia. J Am Vet Med Assoc 2003;222:620-623.
36. Hidalgo-Grass C, Dan-Goor M, Maly A, et al. Effect of a bacterial pheromone peptide on host chemokine degradation in group A Streptococcal necrotising soft-tissue infections. Lancet 2004;363: 696-703.
37. Bazeley PL. Studies with equine streptococci: 3. Vaccination against strangles. Aust Vet J 1942;18:141-155.
38. Collin NC, Chanter N, Mumford JA. Equine infectious diseases VIII, in Proceedings. 8th Int Conf 1999:535-537.
39. Timoney JF. The pathogenic equine streptococci. Vet Res 2004;35:397-409.
40. Flanagan J, Collin N, Timoney J, et al. Characterization of the haemolytic activity of Streptococcus equi. Microb Pathog 1998; 24:211-221.
41. Bentwich Z, Silberstein Z, Boss JH, et al. Cardiac and muscular lesions in mice and rabbits injected with group A Streptococcal products. Pathol Microbiol (Basel) 1968;31:233-242.
42. Basma H, Norrby-Teglund A, Guedez Y, et al. Risk factors in the pathogenesis of invasive group A Streptococcal infections: role of protective humoral immunity. Infect Immun 1999;67:1871-1877.
43. Chatellier S, Ihendyane N, Kansal RG, et al. Genetic relatedness and superantigen expression in group A Streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun 2000;68:3523-3534.
44. Akesson P, Rasmussen M, Mascini E, et al. Low antibody levels against cell wall-attached proteins of Streptococcus pyogenes predispose for severe invasive disease. J Infect Dis 2004;189: 797-804.
45. Norrby-Teglund A, Kotb M. Host-microbe interactions in the pathogenesis of invasive group A streptococcal infections. J Med Microbiol 2000;49:849-852.
46. Kotb M, Norrby-Teglund A, McGeer A, et al. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 2002;8:1398-1404.
47. Stevens DL, Gibbons AE, Bergstrom R, et al. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988;158:23-28.
48. Eagle H. Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice. Am J Med 1952;13:389-399.
49. Stevens DL, Van S, Bryant AE. Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect. J Infect Dis 1993;167:1401-1405.
50. Stevens DL. Streptococcal toxic shock syndrome associated with necrotizing fasciitis. Annu Rev Med 2000;51:271-288.